Quantum BioPharma Ltd (QNTM)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
12.73
1.41 (12.46%)
At close: Feb 10, 2025, 1:04 PM
Company Description
No Company description available at the moment.
Quantum BioPharma Ltd
![Quantum BioPharma Ltd logo](https://financialmodelingprep.com/image-stock/QNTM.png)
Country | n/a |
IPO Date | n/a |
Industry | n/a |
Sector | n/a |
Employees | n/a |
CEO | Zeeshan Saeed |
Contact Details
Address: No Address available No city data available, | |
Website | n/a |
Stock Details
Ticker Symbol | n/a |
Exchange | NASDAQ |
Fiscal Year | n/a |
Reporting Currency | USD |
CIK Code | n/a |
CUSIP Number | n/a |
ISIN Number | CA74764Y2050 |
Employer ID | - |
SIC Code | n/a |
Key Executives
Name | Position |
---|---|
Dr. Lakshmi P. Kotra BPHARM, Ph.D. | Chief Executive Officer of Lucid & Director |
Zeeshan Saeed | Founder, Chief Executive Officer, President & Executive Co-Chairman |
Donal Carroll CPA | Chief Financial Officer & Chief Operating Officer |
Anthony John Durkacz | Founder & Executive Co-Chairman |
Dr. Andrzej Chruscinski M.D., Ph.D. | Vice President of Clinical & Scientific Affairs of Lucid |
Jason D. Sawyer | Head of Finance & Mergers and Acquisitions |
Kevin Cassidy | Vice President of Quality-Lucid |
Maryann Adesso | Corporate Secretary |
Nathan Coyle CPA | Controller |
Randell Mack | President of FSD BioSciences |